Kathryn Timm
Family · Overland Park, KSNPI 1033344122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 627 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 627 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$1K
- CSL Behring$1K
- GSK$841
- Genentech USA, Inc.$733
- plus $5K from 33 others
What the payments were for
- Consulting fees$1071%
- Food & beverage$13,47697%
- Education$2482%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 115 | $3,075 |
| Regeneron Healthcare Solutions, Inc. | 63 | $1,764 |
| Sanofi | 48 | $1,364 |
| CSL Behring | 52 | $1,093 |
| GSK | 52 | $841 |
| Genentech USA, Inc. | 41 | $733 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $716 |
| AbbVie | 36 | $498 |
| Amgen | 20 | $404 |
| Pfizer | 19 | $342 |
| Boston Scientific | 14 | $331 |
| Hospira, Inc. | 22 | $325 |
| Novartis | 18 | $279 |
| Incyte Corporation | 5 | $274 |
| Grifols USA, LLC | 10 | $234 |
| Optinose US, Inc. | 8 | $189 |
| ADMA Biomanufacturing LLC | 9 | $164 |
| Pharming Healthcare, Inc. | 8 | $152 |
| Boehringer Ingelheim | 8 | $142 |
| Lilly USA, LLC | 7 | $121 |
| Hikma Pharmaceuticals USA | 4 | $79 |
| LEO Pharma Inc. | 4 | $78 |
| Sanofi-aventis U.S. LLC | 1 | $77 |
| Teva Pharmaceuticals USA, Inc. | 5 | $74 |
| Kaleo, Inc. | 3 | $58 |
| Biocryst US Sales Co., LLC | 2 | $51 |
| Octapharma USA, Inc. | 3 | $49 |
| Alk-abello, Inc | 2 | $46 |
| Blueprint Medicines Corporation | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $39 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Greer Laboratories, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,830 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
- Christopher PeltonOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.